Remepy raises $36 million Series A as it prepares AI-driven Parkinson’s treatment for Phase III

August 12, 2026

More like this

September 16, 2026

Remepy Welcomes Pharma R&D Leader, Eran Harary, MD, as Chief Medical Officer, to Advance Hybrid Drug™ Pipeline

Press Release

August 19, 2026

Developer raises $36M, will help fund late-stage Parkinson’s clinical trial

Parkinson's News Today

August 13, 2026

Remepy raises US$36m to advance Parkinson’s treatment into Phase III

Health Tech World